Abstract
Background and Aims A low ankle-brachial index (ABI) is associated with a higher risk of cardiovascular diseases, stroke, and systemic inflammation. Intracranial aneurysms (IAs) share similar risk factors with other cardiovascular diseases. However, the association between low ABI and IAs lacks sufficient investigation.
Methods This retrospective study reviewed 2751 patients who had ABI measurements at a tertiary hospital from January 2011 to December 2013. Patients with available cerebrovascular imaging or a diagnosis of ruptured IA were included in the study (n=776) to examine the association between ABI and saccular IAs. The patients were classified into four groups: low ABI (≤0.9, n=464), borderline ABI (0.91-0.99; n=47), high ABI (>1.4, n=57), and normal ABI (1.00-1.40; n=208).
Results The prevalence of IAs was 20.3% (18.1% unruptured IAs) in the low ABI group, 14.9% (12.8% unruptured IAs) in the borderline ABI group, 7.0 % (5.3% unruptured IAs) in the high ABI group, and 2.4% (1.9% unruptured IAs) in the normal ABI group (p<0.001). Sex- and age-adjusted multinomial regression, including clinically relevant variables, revealed that low ABI (odds ratio [OR], 11.33; 95% confidence interval [CI], 4.08-31.51; p<0.001) and borderline ABI (0.91-0.99) (OR, 7.13; 95% CI, 1.91-26.63; p=0.004) were the only variables significantly associated with unruptured IAs.
Conclusions The prevalence of unruptured IAs was 9-fold higher in the low ABI group and nearly 7-fold higher in the borderline ABI group when compared to the normal ABI group. ABI measurements could be clinically relevant for identifying individuals at higher risk of IAs and may help guide screening and preventive strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Maire Taponen foundation (Dr. Laukka), Finnish culture foundation; Varsinais-Suomen fund (grant number 85161416) and Satakunta fund (grant numbers 75212239, 75221501) (Dr Hakovirta), a government research grant awarded to Turku University Hospital (Dr. Laukka, Dr Hakovirta and Dr. Rinne) and a government research grant awarded to Satasairaala (Pori) (Dr Hakovirta).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review board at Turku University Hospital, Finland. Patient consent was not required because of the retrospective nature of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Abstract revision.
Data Availability
The data that support the findings of this study are available from the corresponding author (D.L), upon reasonable request.
